Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 80329 refers to a laboratory test specifically designed to measure the presence of non-opioid analgesics in biological samples such as urine, serum, or plasma. Non-opioid analgesics are a category of medications that are primarily used to alleviate pain without the use of opioids. This category includes various compounds such as salicylates, which are commonly represented by aspirin, acetaminophen, and non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and naproxen sodium. Additionally, selective cyclooxygenase-2 (COX-2) inhibitors, such as Celebrex, fall under this classification. These medications are utilized for the management of both acute and chronic pain, ranging from mild to moderate intensity, and can be prescribed in conjunction with opioids or other analgesics to address more severe pain conditions. Beyond their primary function of pain relief, many of these analgesics also possess anti-inflammatory and anti-pyretic properties, making them versatile in treating various symptoms. The testing process for these compounds involves different methodologies; for instance, salicylates and acetaminophen are typically analyzed using spectrophotometry, while ibuprofen and naproxen sodium are assessed through high-performance liquid chromatography. The specific code 80329 is applicable when testing for one or two non-opioid analgesic compounds, whereas codes 80330 and 80331 are designated for testing three to five and six or more non-opioid analgesics, respectively.
© Copyright 2026 Coding Ahead. All rights reserved.
The laboratory test represented by CPT® Code 80329 is indicated for the measurement of non-opioid analgesics in patients who may be experiencing pain management issues. The specific indications for this test include:
The procedure for conducting the laboratory test associated with CPT® Code 80329 involves several key steps to ensure accurate measurement of non-opioid analgesics. These steps include:
After the completion of the laboratory test associated with CPT® Code 80329, several post-procedure considerations are important for both the patient and the healthcare provider. The results of the test will guide the provider in evaluating the effectiveness of the current pain management strategy. If the levels of non-opioid analgesics are found to be subtherapeutic, adjustments to the medication regimen may be necessary to enhance pain control. Conversely, if levels are elevated, the provider may need to consider reducing the dosage or switching to alternative therapies to mitigate the risk of adverse effects. Additionally, ongoing monitoring may be recommended to ensure that the patient remains within the therapeutic range, particularly if they are on a long-term pain management plan. Communication between the laboratory and the healthcare provider is essential to ensure that the results are interpreted correctly and that appropriate follow-up actions are taken based on the findings.
| Short Descr | ANALGESICS NON-OPIOID 1 OR 2 | Medium Descr | DRUG SCREEN ANALGESICS NON-OPIOID 1 OR 2 | Long Descr | Analgesics, non-opioid; 1 or 2 | Status Code | Not Valid for Medicare Purposes | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Code Not Recognized by OPPS when submitted on Outpatient Hospital Part B Bill Type (12x/13x) | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T2D - Other tests - other | MUE | 1 |
| 26 | Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number. | 91 | Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient. |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2015-01-01 | Added | Added |
Get instant expert-level medical coding assistance.